Form EFFECT Evoke Pharma Inc
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 |
| Accession Number: | 0001193125-25-322655 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bitcoin Price News: BTC Trades Near $81,600 as Remittix Nears $33 Million Raised and Its November 24 Debut
- Best Crypto to Buy in 2026: BONK, FLOKI or Remittix as Meme Coins Pull Back and PayFi Testing Advances?
- Bitcoin News: Strategy’s MSCI Eligibility Comes Under Pressure as Remittix Approaches Its November Market Debut
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share